Surgery Doctors in Middletown, NY Accepting Medicare

25 Surgery doctors found. Showing 21 - 25

Robert G. Kulak, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 236 Crystal Run Road, Middletown, NY 10941 Phone: 845-692-3111    Fax: 845-692-0125

Jaime Cepeda, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 384 Crystal Run Rd Ste 201, Middletown, NY 10941 Phone: 845-692-8780

Dr. Robert Mark Lincer, M.D. Surgery - Surgical Oncology Medicare: Accepting Medicare Assignments Practice Location: 707 E Main St, Middletown, NY 10940 Phone: 845-333-7575    Fax: 845-333-7202

Elliot Mayefsky, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 236 Crystal Run Rd, Middletown, NY 10941 Phone: 845-692-3111    Fax: 845-692-0125

Dr. Nicole Marie Mcgill, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 707 E Main St, Middletown, NY 10940 Phone: 845-333-1000

News Archive

Latin women of European ancestry at greater risk for breast cancer

Latina women have a lower risk of breast cancer than European or African-American women generally, but those with higher European ancestry could be at increased risk, according to data published in the December 1 issue of Cancer Research , a journal of the American Association for Cancer Research.

Tension between awareness and fatigue can shift the shape of coronavirus pandemic

In the midst of the coronavirus pandemic, two human factors are battling it out: awareness of the virus's severe consequences and fatigue from nine months of pandemic precautions.

New NCCN patient guide for Waldenström's Macroglobulinemia helps make informed treatment decisions

A very rare sub-type of Non-Hodgkin's Lymphoma, Waldenström's Macroglobulinemia affects approximately 1,500 - 2,000 people in the United States each year. While it is not curable, Waldenström's Macroglobulinemia is slow growing, and in many patients, manageable as a chronic disease.

JunD promotes epithelial-to-mesenchymal transition by association with NEAT1 lncRNA

Oncotarget published "JunD accentuates arecoline-induced disruption of tight junctions and promotes epithelial-to-mesenchymal transition by association with NEAT1 lncRNA" which reported that the effects of low and high concentrations of arecoline on the stability of tight junctions and EMT induction were studied.

Read more Medical News

› Verified 9 days ago

• 1
• 2(current)